TransThera Sciences (Nanjing), Inc. (HKG:2617)

HKG:2617 Revenue

TransThera Sciences (Nanjing) had revenue of 35.46M CNY in the half year ending June 30, 2026. This brings the company's total for the last twelve months to 35.46M. That makes TransThera Sciences (Nanjing) the 39,814th largest company in the world by revenue and 2,437th in Hong Kong.

• Revenue (ttm): 35.46M CNY
• Revenue Growth: n/a
• P/S Ratio: 90.25
• Revenue / Employee: 268.60K CNY
• Employees: 132
• Market Cap: 3.48B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	1.18M	1.06M	852.42%
Dec 31, 2022	124.00K	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 21, 2026

Data Sources Report a data error